Hester Biosciences Limited (HESTERBIO.BO)

INR 2469.0

(1.32%)

Market Cap (In INR)

21 Billion

Revenue (In INR)

3.04 Billion

Net Income (In INR)

188.89 Million

Avg. Volume

1375.00

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1292.9-3375.45
PE
-
EPS
-
Beta Value
0.699
ISIN
INE782E01017
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Rajiv Dinesh Gandhi B.Com
Employee Count
-
Website
https://www.hester.in
Ipo Date
Details
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare, and Others segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, fowl typhoid, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian coccidiosis, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucellosis, contagious bovine pleuropneumonia, and lumpy skin diseases. In addition, the company provides animal health products, such as biosecurity and therapeutic solutions, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticide solutions, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides enzyme-linked immunosorbent assay and polymerase chain reaction diagnostic kits. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

More Stocks